II Robert C. Goeltz
CIK 1653881 · Chief Financial Officer · last filed 2026-05-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.07M
Companies
3
Total Filings
38
Lifetime Open-Market Net
-$1.47M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RCUS | Chief Financial Officer | 84,161 | $23.80 | $2.00M | -$1.04M | 21 | 2026-05-12 |
| Unity Biotechnology, Inc. (UBX) Delisted | Chief Financial Officer | 161,027 | $0.20 | $32.2K | $0 | 8 | 2020-06-24 |
| CTMX | Chief Financial Officer | 22,769 | $3.01 | $68.5K | -$426.3K | 9 | 2017-05-16 |
Recent Filings · Page 3 of 4
38 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-08-04 | RCUS | Grant (A) | — | $0 | EDGAR |
| 2020-06-24 | Unity Biotechnology, Inc. (UBX) Delisted | Tax (F) | −2,483 | -$24.0K | EDGAR |
| 2020-04-01 | Unity Biotechnology, Inc. (UBX) Delisted | Grant (A) | +29,106 | $0 | EDGAR |
| 2020-02-26 | Unity Biotechnology, Inc. (UBX) Delisted | Exer (M) | +10,000 | $34.3K | EDGAR |
| 2019-09-23 | Unity Biotechnology, Inc. (UBX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-24 | Unity Biotechnology, Inc. (UBX) Delisted | Grant (A) | +21,075 | $0 | EDGAR |
| 2018-10-12 | Unity Biotechnology, Inc. (UBX) Delisted | Exer (M) | +5,000 | $17.1K | EDGAR |
| 2018-05-07 | Unity Biotechnology, Inc. (UBX) Delisted | Conv (C) | +1,630 | $0 | EDGAR |
| 2018-05-04 | Unity Biotechnology, Inc. (UBX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-05-16 | CTMX | Exer (M) | +19,967 | $110.7K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.